91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

ambrisentan

别名 Letairis®
Compound Class Synthetic organic
变动原因 Ambrisentan is an endothelin receptor antagonist, with selectivity for the type A endothelin receptor (ETA).

Summary

是否批准为药物? (FDA (2007), EMA (2008))
IUPAC Name (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid
别名 Letairis®

生物活性

生物活性评价 The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in ).
关联靶标 ETA receptor , ETA receptor , ETB receptor

临床资料

Summary of Clinical Use Approved to treat pulmonary arterial hypertension (PAH).
Ambrisentan is being evaluated in Phase 3 clinical trial for the additional indication chronic thromboembolic pulmonary hypertension.

COVID-19: In response to the SARS-CoV-2 pandemic, clinical trials were initiated to address the potential of endothelin receptor antagonism as a treatment for endothelial cell damage and dysfunction in the blood vessels (in the lungs and other organs) that occurs during SARS-CoV-2 infection.
作用机制与药效学效应 Ambrisentan is a selective endothelin receptor A (ETA) antagonist. Antagonism of endothelin binding to ETA decreases vasoconstriction in the smooth muscle of the lungs and reduces pulmonary blood pressure.

结构

Canonical SMILES COC(C(C(=O)O)Oc1nc(C)cc(n1)C)(c1ccccc1)c1ccccc1
Isomeric SMILES COC([C@@H](C(=O)O)Oc1nc(C)cc(n1)C)(c1ccccc1)c1ccccc1
InChI InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
InChI key OUJTZYPIHDYQMC-LJQANCHMSA-N

91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

品牌简介

{转码主词}